. Impaired binding would then facilitate increased urate deposition, with the consequent development of gouty arthritis and tophus formation (Seegmiller and Howell, 1962) . Alvsaker (1966) has postulated the deficiency of a specific urate-binding globulin in some patients having primary gout. During experiments designed to characterize the urate-binding properties of human plasma, however, it was noted that salicylate significantly impaired urate binding (Klinenberg, 1968 Collection of Samples.-Thirty ml. of blood was drawn by venepuncture into heparinized tubes from all subjects before treatment (day 0), and further samples were obtained on days 3 and 8. Post-therapy samples were obtained on days 10 and 12 and, in some instances, on day 19. Blood samples were centrifuged, and the plasma was separated, divided into 3-ml. aliquots, and frozen until assayed (no longer than 14 days).
Assays
Aliquots from each sample were assayed for total plasma protein, albumin, and uric acid concentrations and urate binding capacity. Total plasma protein concentrations were determined by the modified biuret technique of Gornall et al. (1949~) .
Albumin was assayed by cellulose acetate electrophoresis, using a Beckman microzone electrophoresis system. Plasma urate was determined by the enzymatic spectrophotometric method of Liddle et al. (1959) .
Plasma-urate-binding capacity was assayed by a method of equilibrium dialysis recently reported (Klinenberg and Kippen, 1969) . Three-ml. plasma aliquots were dialysed for 16 hours at 4°C. against large volumes of 0-01 M phosphate buffer containing 15 mg. uric acid per 100 ml. buffer. The plasma samples from one subject given allopurinol and from another given probenecid were also dialysed against buffers containing 5 and 10 mg. uric acid per 100 ml. buffer. After equilibration the amount of uric acid within the dialysis bag in excess of that in the buffer was considered to be bound. The amount of uric acid bound was expressed as jug./ml. plasma.
In order to compare urate binding capacity of a number of samples by this technique, it is necessary to select one or more free urate concentrations as points of reference. Fifteen mg. per cent. urate was selected because there is a linear relationship between urate binding to plasma and free urate concentration up to 20 mg. urate per 100 ml. (Klinenberg and Kippen, 1969) , and because the ability to detect differences between samples is greater at higher free urate concentrations.
DEAE-Sephadex Chromatography
Ion exchange chromatography was performed on plasma aliquots obtained from one subject on day 0 and on day 8 after probenecid or phenylbutazone therapy. DEAE-Sephadex (A-50) columns were prepared according to the manufacturer's recommendations and equilibrated with 0 05 M sodium phosphate buffer, pH 7-35. Samples were eluted with 0-01 M sodium phosphate buffer, pH 7*35, containing 0-2 M sodium chloride. This procedure produced three distinct peaks, the third of which was shown to be predominantly albumin and accounted for most of the urate-binding capacity of normal plasma. These albumin peaks were dialysed exhaustively against 0 01 H phosphate buffer and lyophilized. The uratebinding capacities of the redissolved albumin fractions were then measured by equilibrium dialysis.
Results
Plasma Proteins.-No significant alterations in total plasma protein or albumin concentrations were detected in any subject throughout the period of study.
Plasma Urate.-The effect of the drugs on plasma urate concentrations is shown in Table I . Allopurinol, aspirin, phenylbutazone, probenecid, and sulphinpyrazone significantly reduced the plasma urate concentrations. Urate concentrations returned to pre-drug values by day 12 following the administration of all the drugs except for phenylbutazone (Fig. 1) . No significant depression of plasma urate was observed after the administration of colchicine or indomethacin. 15-5 (±2 8) [kg./ml. (P<0-001) , and phenylbutazone from 24-3 (±1-2) to 13-8 (±0-7) Ag./ml. (P<0-001). The impaired binding associated with all three drugs was apparent by day 3 following their administration (Fig. 2) (Shinaberger et al., 1964) . It is thus possible that impairment of irate binding in vivo might result in more "free" uric acid being available for deposition within the tissues. Conversely, the binding of a significant proportion of plasma urate in hyperuricaemic subjects might play a protective part in the prevention of acute gout.
The three drugs which caused impaired urate binding in the doses administered are known uricosuric agents. Although it is postulated that uricosuric agents exert their main effect at the renal tubular level (Gutman and Yu, 1958) , it is conceivable that their inhibition of urate binding could facilitate an increased glomerular urate clearance, with subsequent augmentation of the uricosuric effect. It has been thought that, normally, uric acid is completely cleared at the renal glomerulus (Yu and Gutman, 1953) . Bound urate, however, might not be freely filtered at the glomerulus, and clearance would then not be complete. Not all uricosuric drugs, however, impair urate binding. Thus the subjects taking sulphinpyrazone all demonstrated uricosuria but had normal urate binding.
If a uricosuric drug were to impair urate binding in a hyperuricaemic subject before adequate uricosuria occurred, then urate released from the protein might facilitate the production of gout. This might partially explain the well-recognized exacerbation of gouty arthritis which sometimes occurs during initiation of uricosuric therapy. It might also account for the relative ineffectiveness of uricosuric doses of aspirin in preventing acute gout.
The precise mechanism for drug inhibition of urate binding to plasma proteins has not yet been delineated. The fact that ion exchange chromatography restored normal urate binding capacities to the plasma albumin fractions suggests that a gross structural change of albumin molecules is unlikely. In addition, no quantitative changes in plasma protein or albumin levels during drug administration were detected. Aspirin has been shown to result in acetylation of albumin in vivo (Hawkins et al., 1969) (Brodie, 1965) , including salicylate anions (Odell et al., 1969) , indomethacin, phenylbutazone (Aggeler et al., 1967) , and sulphinpyrazone. Furthermore, salicylate, phenylbutazone, and probenecid seem to share a common binding site on the albumin molecule (Whitehouse, personal communication, 1969) . Since the urate/ protein bond is a weak one, displacement of urate by a drug would be facilitated. The failure of indomethacin, a drug which is extensively protein-bound, to produce significant impairment of urate binding may be explained by the low plasma drug concentrations achieved with normal doses of indomethacin (Hucker et al., 1966) . Likewise, the failure of sulphinpyrazone to impair urate binding significantly may reflect the fact that it may have a different binding site from the other drugs on the albumin molecule (Whitehouse, personal communication, 1969) . Allopurinol is not protein-bound (Elion et al., 1966) , and apparently does not affect urate binding. The binding of colchicine, and its metabolism, is not well understood, and in any event the small doses administered in this study would result in low plasma concentrations (Ertel et al., 1969 (Alvsaker, 1968 Uchiyama, 1950) and that it may be difficult to change the faecal E. coli population (Sears, Janes, Saloum, Brownlee, and Lamoreaux, 1956) . Kennedy, Plorde, and Petersdorf (1965) and Winterbauer, Turck, and Petersdorf (1967) , however, have shown that certain serotypes of E. coli are more commonly found in the faeces of hospital inpatients than in the general population, suggesting that under these conditions the E. coli bowel flora may change.
The investigations reported here were carried out to study in some detail the faecal carriage of E. coli by patients in one hospital ward.
Material and Methods
The work was done during one year in a female open medical ward which had 24 beds and one further bed in a single side-room. The patients were those seen in a general medical ward, and included particularly diabetic patients and patients with diseases of the bowel.
Specimens of Faeces.-We tried to obtain specimens from each patient as soon as possible after admission and thereafter at weekly intervals. In addition each stool passed by 32 patients during one week was examined.
Specimens of Urine.-These were midstream specimens sent in routinely because urinary tract infection was suspected. The presence of an excess of white cells in the urine and of a bacilluria (of 105 or more) were the criteria taken for considering the patient to be infected.
Method of Faeces Examination
The faeces were inoculated on to a MacConkey plate by means of a cotton-wool swab. After overnight incubation the plates were examined and five colonies of each colonial type of coliform present were subcultured on to blood agaT. The identity of these coliforms as Escherichia was confirmed by determination of the following reactions: fermentation of lactose and glucose, production of indole, and failure to produce urease or to utilize citrate. The E. coli were inoculated into 10 ml. of broth which was incubated overnight, steamed for 30 minutes, and then used for serotyping the organism.
Antisera to 0 groups 1-25, 39, and 75 were prepared by the method of Roschka (1950) . The cross-reactions of the antisera with the type strains of 148 E. coli 0 groups were determined, and absorbed sera were prepared as described by Bettelheim and Taylor (1969) .
The antisera were grouped into five pools; 0*3 ml. of bacterial suspension was added to 0 3 ml. of antiserum in a Dreyer's tube, incubated at 500 C. for 18 hours, and then read. When a positive result was obtained the organism was tested against the monovalent antisera of the group. The identity of the organisms was confirmed by titration of the antisera, and, when necessary, by use of absorbed antisera.
Results
Examination of 1,136 specimens of faeces from 303 patients was made. From 234 of the patients typable strains of E. coli
